Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining

被引:14
|
作者
Rao, Ram Nawal [1 ]
Ranjan, Priydarshi [2 ]
Singla, Nidhi [1 ]
Pandey, Rakesh [1 ]
机构
[1] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pathol, Raibarely Rd, Lucknow, Uttar Pradesh, India
[2] Sanjay Gandhi Postgrad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India
关键词
Anaplastic lymphoma kinase-1; inflammatory myofibroblastic tumor; sarcomatoid urothelial carcinoma; urinary bladder;
D O I
10.4103/0974-7796.95567
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Inflammatory myofibroblastic tumor (IMFT) of the urinary bladder is an unusual spindle cell lesion that exhibits cytologic atypia, infiltrative growth, and mitotic activity mimicking malignant tumors, such as leiomyosarcoma, rhabdomyosarcoma, and sarcomatoid carcinoma. Recently, anaplastic lymphoma kinase (ALK) gene translocations or ALK protein expression in IMFT has been reported, especially in patients of children and young adults. This lesion has been described in numerous locations in addition to the urinary bladder. The detection of ALK protein and ALK gene rearrangements are useful in distinguishing IMFT from spindle cell malignancies in the urinary bladder.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 50 条
  • [1] Urinary bladder inflammatory myofibroblastic tumor
    Saritas, Ahmet Gokhan
    Dalci, Kubilay
    Gonlusen, Gulfiliz
    Erdogan, Seyda
    Rencuzogullari, Ahmet
    CUKUROVA MEDICAL JOURNAL, 2018, 43 (02): : 487 - 490
  • [2] Primary intraocular inflammatory myofibroblastic tumor with anaplastic lymphoma kinase overexpression
    Alfredo E. Romero-Rojas
    Julio A. Diaz-Perez
    Melina Mastrodimos
    Jose Szelezsan
    Oscar Messa-Botero
    International Ophthalmology, 2014, 34 : 667 - 673
  • [3] Primary intraocular inflammatory myofibroblastic tumor with anaplastic lymphoma kinase overexpression
    Romero-Rojas, Alfredo E.
    Diaz-Perez, Julio A.
    Mastrodimos, Melina
    Szelezsan, Jose
    Messa-Botero, Oscar
    INTERNATIONAL OPHTHALMOLOGY, 2014, 34 (03) : 667 - 673
  • [4] Anaplastic lymphoma kinase1 positive inflammatory myofibroblastic tumor of the urinary bladder: A rare mesenchymal neoplasm with diagnostic and therapeutic implications
    Poombal, Fnu
    Mansoor, Ibrahim
    Abdellatif, Randa M.
    Shaker, Nada
    SAGE OPEN MEDICAL CASE REPORTS, 2024, 12
  • [5] Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosis
    Chun, YS
    Wang, LN
    Nascimento, AG
    Moir, CR
    Rodeberg, DA
    PEDIATRIC BLOOD & CANCER, 2005, 45 (06) : 796 - 801
  • [6] Anaplastic Lymphoma Kinase Inhibitor in Treatment of Inflammatory Myofibroblastic Tumor of the Tongue in Infancy
    Rao, Karishma
    Farooki, Sana
    Guest, Erin
    Chastain, Katherine
    Gener, Melissa
    Akangire, Gangaram
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : E521 - E524
  • [7] Inflammatory myofibroblastic tumor of the urinary bladder
    Yagnik, Vipul
    Chadha, Amit
    Chaudhari, Sanjay
    Patel, Keyuri
    UROLOGY ANNALS, 2010, 2 (02) : 78 - 79
  • [8] Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype
    Hisaoka, M
    Shimajiri, S
    Matsuki, Y
    Meis-Kindblom, JM
    Kindblom, LG
    Li, XQ
    Wang, J
    Hashimoto, H
    PATHOLOGY INTERNATIONAL, 2003, 53 (06) : 376 - 381
  • [9] Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report
    Tanny, Sharman P. Tan
    Wang, Luke L.
    Liddell, Heath A.
    Longano, Anthony
    Appu, Sree
    Shahbaz, Shekib
    UROLOGY CASE REPORTS, 2016, 6 : 58 - 59
  • [10] Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene
    Saiki, Masafumi
    Ohyanagi, Fumiyoshi
    Ariyasu, Ryo
    Koyama, Junji
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) : 1189 - 1192